---
title: "C-MER Medical Holdings Limited (03309.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/03309.HK.md"
symbol: "03309.HK"
name: "C-MER Medical Holdings Limited"
industry: "Health Care Facilities"
---

# C-MER Medical Holdings Limited (03309.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Facilities |
| Location | HK Market |
| Website | [www.cmermedical.com](https://www.cmermedical.com) |

## Company Profile

C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. It operates through five segments: HK Medical Business, Sales of Medical Consumables, Mainland China Ophthalmic Business, Mainland China ...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-15T04:30:11.000Z

**Overall: C (0.52)**

**Industry**: Health Care Facilities

| Metric | Value |
|--------|-------|
| Industry Ranking | 6 / 18 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.05% |  |
| Net Profit YoY | -284.09% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.01 |  |
| Dividend Ratio | 1.38% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.81B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.93B |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -6.41% | D |
| Profit Margin | -5.99% | D |
| Gross Margin | 31.12% | C |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.05% | C |
| Net Profit YoY | -284.09% | E |
| Total Assets YoY | -0.42% | D |
| Net Assets YoY | -3.08% | D |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1668.35% | E |
| OCF YoY | 2.05% | C |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.70 | B |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 29.80% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - C-MER Medical Holdings Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-6.41%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-5.99%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "31.12%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "2.05%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-284.09%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.42%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-3.08%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1668.35%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "2.05%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.70",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "29.80%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | SAINT BELLA (HK.2508) | D | A | B | B | B | B |
| 02 | HYGEIA HEALTH (HK.6078) | C | D | C | B | C | C |
| 03 | BAYZED HEALTH (HK.2609) | D | C | C | B | D | C |
| 04 | CR MEDICAL (HK.1515) | C | C | B | C | C | C |
| 05 | CHAOJU EYE CARE (HK.2219) | B | D | C | A | C | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -15.57 | 17/19 | 39.66 | 35.07 | 34.08 |
| PB | 1.01 | 13/19 | 1.32 | 1.24 | 1.14 |
| PS (TTM) | 0.93 | 11/19 | 1.22 | 1.15 | 1.04 |
| Dividend Yield | 1.38% | 9/19 | 1.23% | 1.11% | 1.04% |

## Institutional View

### Analyst Rating Distribution

> As of 2024-04-24T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.49 |

## References

- [Company Overview](https://longbridge.com/en/quote/03309.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/03309.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/03309.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.